Cyclacel Pharma (CYCC) Reports Q1 Loss Per Share of $0.19
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
ANAB, ANIX, MNY, More
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.19), versus ($0.25) reported last year. Revenue for the quarter came in at $512 thousand, versus $396 thousand reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
- DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
